Seres Therapeutics Inc.
MCRB | NASDAQ
$4.08
+$0.01 (+0.25%)
Sep 22, 2026, 11:09 AM ET · Market open
Market Data
Market Cap $39.41M
Enterprise Value $80.46M
Beta 0.22
Average Volume 78.76K
Shares Outstanding (Diluted) 9.64M
Shares Change YoY 10.3%
Institutional Ownership 24.07%
Exchange NASDAQ
ISIN US81750R2013
Price Performance
Price Change 1M -9.3%
Price Change 3M -42.3%
Price Change 6M -55.5%
Price Change YTD -73.1%
Price Change 1Y -75.4%
Price Change 3Y -92.2%
Price Change 5Y -97.1%
1M CAGR (ann.) -16.4%
1Y CAGR (ann.) -77.4%
5Y CAGR (ann.) -49.0%
All-Time CAGR -38.9%
Valuation
PE Ratio -1.69
Forward PE N/A
PEG Ratio 0.00
Forward PEG -0.04
PS Ratio 20.93
Forward PS 144.10
PB Ratio 1.14
P/FCF Ratio -0.58
P/Adj. FCF Ratio -0.50
P/OCF Ratio -0.77
EV/Sales 42.73
EV/EBIT -1.67
EV/EBITDA -1.81
EV/FCF -1.19
Earnings Yield -59.2%
FCF Yield -171.7%
Adj. FCF Yield -199.4%
Financial Health
Net Cash $15.59M
Total Debt $56.64M
Cash & Short-Term Investments $15.59M
Total Assets $101.59M
Current Ratio 2.11
Quick Ratio 2.11
Debt / Equity Ratio 1.64
Debt / EBITDA -1.28
Debt / FCF -0.84
OCF / Debt -1.19
Interest Coverage 0.00
Altman Z-Score -14.55
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 82.6%
Operating Profit Margin -4462.8%
EBITDA Margin -2354.9%
Net Profit Margin -1192.9%
FCF Margin -3592.9%
Adj. FCF Margin -4174.6%
SBC / Revenue 487.8%
SBC Impact (per share) -16.2%
Returns
Return on Assets -22.1%
Return on Equity -60.3%
Return on Invested Capital -90.0%
Return on Capital Employed -103.0%
Return on Tangible Assets -22.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -75.7%
Revenue CAGR 5Y -42.5%
Revenue CAGR 10Y -10.5%
EPS CAGR 3Y 93.8%
EPS CAGR 5Y 35.4%
EPS CAGR 10Y 13.7%
FCF CAGR 3Y 56.1%
FCF CAGR 5Y 4.0%
FCF CAGR 10Y -2.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 18
EPS Growth Next 3Y -85.7%
Revenue Growth Next 3Y -33.8%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$1
EPS Growth Est (next Q) -206.9%
Revenue Est (next Q) $6.35M
Revenue Growth Est (next Q) 1709.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $12
Price Target Upside 194.8%
Cash Flow
Operating Cash Flow $-67.62M
Free Cash Flow $-67.66M
Adj. Free Cash Flow $-78.61M
FCF Per Share -$5.32
OCF Per Share -$5.31
OCF/S Ratio -2722.1%
Income Statement
Revenue $1.88M
Gross Profit $1.56M
Operating Income $-84.03M
EBITDA $-44.34M
Net Income $-22.46M
EPS (Diluted) -$2.41
Revenue / Employee $28.53K
Profit / Employee $-340.35K
Employees 66
Add to Watchlist
Select watchlists to add or remove MCRB